Steven M. Graves

2.5k total citations
31 papers, 1.1k citations indexed

About

Steven M. Graves is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Steven M. Graves has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 13 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Steven M. Graves's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Neuroscience and Neuropharmacology Research (15 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Steven M. Graves is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Neuroscience and Neuropharmacology Research (15 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Steven M. Graves collaborates with scholars based in United States, Sweden and Australia. Steven M. Graves's co-authors include D. James Surmeier, Weixing Shen, T. Celeste Napier, Shenyu Zhai, Paul Greengard, C. Savio Chan, Luke E. Sebel, Asami Tanimura, Cristina Alcacer and Tim Fieblinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Neuroscience.

In The Last Decade

Steven M. Graves

30 papers receiving 1.1k citations

Peers

Steven M. Graves
Xiomara A. Perez United States
Steven M. Graves
Citations per year, relative to Steven M. Graves Steven M. Graves (= 1×) peers Xiomara A. Perez

Countries citing papers authored by Steven M. Graves

Since Specialization
Citations

This map shows the geographic impact of Steven M. Graves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Graves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Graves more than expected).

Fields of papers citing papers by Steven M. Graves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Graves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Graves. The network helps show where Steven M. Graves may publish in the future.

Co-authorship network of co-authors of Steven M. Graves

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Graves. A scholar is included among the top collaborators of Steven M. Graves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Graves. Steven M. Graves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Graves, Steven M., et al.. (2023). Isradipine, an L-type calcium channel inhibitor, attenuates cue-associated methamphetamine-seeking in mice. Brain Research. 1818. 148528–148528. 1 indexed citations
4.
Graves, Steven M., et al.. (2023). Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice. International Journal of Molecular Sciences. 24(17). 13039–13039. 5 indexed citations
5.
Graves, Steven M., et al.. (2022). Differential vulnerability of locus coeruleus and dorsal raphe neurons to chronic methamphetamine-induced degeneration. Frontiers in Cellular Neuroscience. 16. 949923–949923. 6 indexed citations
6.
Persons, Amanda L., et al.. (2021). Gut and brain profiles that resemble pre-motor and early-stage Parkinson’s disease in methamphetamine self-administering rats. Drug and Alcohol Dependence. 225. 108746–108746. 8 indexed citations
7.
Graves, Steven M., et al.. (2021). Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons. Neurobiology of Disease. 156. 105409–105409. 25 indexed citations
8.
Graves, Steven M., Zhong Xie, Kristen A. Stout, et al.. (2019). Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain. Nature Neuroscience. 23(1). 15–20. 121 indexed citations
9.
Graves, Steven M. & D. James Surmeier. (2019). Delayed Spine Pruning of Direct Pathway Spiny Projection Neurons in a Mouse Model of Parkinson’s Disease. Frontiers in Cellular Neuroscience. 13. 32–32. 33 indexed citations
10.
Graves, Steven M., et al.. (2019). Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson’s Disease. Frontiers in Neural Circuits. 13. 17–17. 4 indexed citations
11.
Zhai, Shenyu, Weixing Shen, Steven M. Graves, & D. James Surmeier. (2019). Dopaminergic modulation of striatal function and Parkinson’s disease. Journal of Neural Transmission. 126(4). 411–422. 66 indexed citations
12.
Zhai, Shenyu, Asami Tanimura, Steven M. Graves, Weixing Shen, & D. James Surmeier. (2017). Striatal synapses, circuits, and Parkinson's disease. Current Opinion in Neurobiology. 48. 9–16. 123 indexed citations
13.
Sebel, Luke E., Steven M. Graves, C. Savio Chan, & D. James Surmeier. (2016). Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits. Neuropsychopharmacology. 42(4). 963–973. 21 indexed citations
14.
Fieblinger, Tim, Steven M. Graves, Luke E. Sebel, et al.. (2014). Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia. Nature Communications. 5(1). 5316–5316. 225 indexed citations
15.
Graves, Steven M., Mary J. Clark, John R. Traynor, Xiu‐Ti Hu, & T. Celeste Napier. (2014). Nucleus accumbens shell excitability is decreased by methamphetamine self-administration and increased by 5-HT2C receptor inverse agonism and agonism. Neuropharmacology. 89. 113–121. 25 indexed citations
16.
Graves, Steven M., et al.. (2012). The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization. Brain Research. 1472. 45–53. 16 indexed citations
17.
Graves, Steven M. & T. Celeste Napier. (2012). SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats. BMC Neuroscience. 13(1). 65–65. 31 indexed citations
18.
Graves, Steven M., et al.. (2012). Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: Evidence from the bench and the bedside. Pharmacology & Therapeutics. 136(3). 343–353. 32 indexed citations
19.
McGinty, Vincent B., Benjamin Y. Hayden, Sarah R. Heilbronner, et al.. (2011). Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference. Behavioural Brain Research. 225(1). 348–357. 18 indexed citations
20.
Graves, Steven M. & T. Celeste Napier. (2010). Mirtazapine Alters Cue-Associated Methamphetamine Seeking in Rats. Biological Psychiatry. 69(3). 275–281. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026